Stock
Ticker
First
Article
Original
Price
Price
Today
VUZI July 27 9.10 Check
OMEX July 18 3.18 Check
DGLY July 15 5.95 Check
RSYS June 28 4.63 Check
CPRT June 28 46.98 Check
STRP June 22 30.24 Check
SEDG June 23 20.68 Check
KEM June 21 2.94 Check
SGRY June 15 17.47 Check
MOC June 7 3.08 Check
RLYP June 9 19.98 Check
MITK June 2 9.09 Check
VUZI May 23 5.57 Check
MGT May 17 4.98 Check
CDE May 16 8.66 Check
TRUP May 10 15.17 Check
ADMP May 4 9.31 Check
GPL May 5 2.25 Check
SKY Apr 26 11.37 Check
BPTH Apr 26 2.83 Check
AAU Apr 19 1.35 Check
RELY Apr 13 9.93 Check
HIMX Apr 11 11.50 Check
OMEX Apr 7 8.87 Check
USCR Mar 30 63.67 Check
BRKO Mar 10 3.51 Check
KEYW Mar 3 7.00 Check
EYES Feb 23 6.93 Check
CPXX Feb 29 2.32 Check
TRXC Feb 26 3.62 Check
SLP Feb 22 10.20 Check
VHC Feb 10 7.50 Check
AMDA Feb 3 3.18 Check
ADAT Jan 28 5.0 Check
LPTH Jan 26 3.27 Check
AMSC Jan 20 6.17 Check
WNDW Jan 14 3.45 Check
NG Jan 7 4.33 Check
OLED Dec 12 53.67 Check
NCTY Dec 10 3.85 Check
PAYC Dec 2 44.02 Check
ZAGG Dec 1 10.45 Check
CALL Nov 25 10.23 Check
VLTC Nov 24 8.60 Check
TITN Nov 17 12.40 Check
BMI Nov 3 60.47 Check
HEAR Oct 26 3.45 Check
MNGA Oct 22 1.47 Check
MEET Oct 16 2.40 Check
WIFI Oct 8 8.10 Check
AVXLD Oct 6 5.80 Check
TRCH Sept 24 2.09 Check
CLIR Sept 16 6.79 Check
FENX Sept 10 9.49 Check
FTK Sept 2 20.27 Check
GTT Aug 27 22.40 Check
EFOI Aug 19 17.89 Check
VG Aug 11 6.40 Check
TRUP Aug 10 8.43 Check
TCX Aug 8 26.41 Check
LJPC Jul 13 32.87 Check
KRNT Jul 6 14.72 Check
UEC Jun 18 2.61 Check
EMAN Jun 11 2.90 Check
NWBO Jun 10 10.29 Check
DMRC Jun 3 30.00 Check
PTBI May 28 9.10 Check
ICLD May 29 3.15 Check
HOTR May 19 3.98 Check
CDTI May 15 2.25 Check
GEVO May 13 5.68 Check
QNST May 12 5.52 Check
CLNE May 5 10.10 Check
CHOP Apr 24 3.72 Check
INUV Apr 16 2.92 Check
UNXL Apr 10 7.31 Check
HRTX Apr 4 14.25 Check
MVIS Mar 23 4.02 Check
CRMD Mar 19 8.35 Check
RESN Mar 10 14.47 Check
ANTH Mar 9 6.16 Check
EYES Mar 2 17.66 Check
BLDP Feb 19 2.71 Check
ONDK Feb 11 17.51 Check
JMBA Feb 9 16.50 Check
MIFI Feb 9 5.47 Check
ZIOP Jan 16 8.23 Check
FRPT Dec 11 18.90 Check
RDCM Dec 3 10.36 Check
RCPT Nov 17 106.55 Check
URRE Nov 13 2.49 Check
PHMD Oct 29 4.16 Check
IBIO Oct 23 1.77 Check
VIMC Oct 23 9.64 Check
SZYM Oct 16 6.96 Check
AXDX Oct 14 27.38 Check
GLUU Oct 7 5.12 Check
MILL Sept 19 4.96 Check
DGLY Sept 16 20.65 Check
MNDL Aug 26 5.35 Check
FCEL Aug 20 2.76 Check
SYMX Aug 7 1.20 Check
ADES July 11 22.70 Check
TTGT June 19 8.19 Check
ANY.V May 28 9.42 Check
CYBX Apr 16 62.24 Check
OPTT Apr 4 4.19 Check
MDXG Mar 21 7.01 Check
AMRS Mar 7 4.85 Check
UNIS Feb 27 4.65 Check
PHMD Oct 17 15.49 Check
TXMD Feb 14 6.36 Check
SGMO Sept 19 11.21 Check
ZEN.V Sept 9 3.78 Check
XONE Aug 28 71.90 Check
TEAR Aug 1 14.40 Check
CNDO July 15 8.65 Check
RVLT July 2 4.03 Check
LOTE May 5 10.00 Check
LULU April 18 71.34 Check
PSSI Oct 3 23.00 Check
TNGO Aug 28 19.55 Check
MDVN May 31 $85.01 Check
JIVE May 3 $24.09 Check
SNPK April 3 $1.70 Check
QCOR Jan. 11 $41.54 Check
BRLI Nov. 1 $20.04 Check
PANL Oct. 3 $47.94 Check
GORO Aug. 23 $24.32 Check
MILL July 28 $7.04 Check
CIGX June 30 $4.51 Check
JAMN May 16 $5.17 Check
SWSH May 2 $8.77 Check
LEXG April 26 $4.02 Check
NOG March 21 $28.25 Check
VOG March 21 $5.02 Check
HNHI Feb. 17 $1.46 Check
IBIO Feb. 10 $5.17 Check
COUGF Feb. 1 $3.36 Check
LLEN Jan. 11 $10.27 Check
HHWW Dec. 23 $1.63 Check
CYDE Dec. 2 $3.29 Check
SMED Oct. 14 $5.87 Check
RMCP Sept. 21 $0.69 Check
INET Sept. 13 $10.66 Check
CLKZ Aug. 30 $0.53 Check
LQMT Aug. 19 $0.76 Check
LOCM Aug. 4 $6.12 Check
ESPH June 25 $1.49 Check
APOL June 15 $47.60 Check
BPI June 15 $19.63 Check
SILA May 27 $1.14 Check
FLPC May 27 $0.97 Check
AMEL May 27 $1.05 Check
STP May 17 $10.62 Check
BGBR April 26 $1.21 Check
NNLX April 16 $1.10 Check
CHTL April 9 $0.74 Check
AMLM March 25 $1.02 Check
LTUM March 25 $1.25 Check
TRGL March 11 $9.56 Check
TSHO Feb 24 $1.16 Check
CSKI Feb 19 $18.30 Check
GXDX Feb 15 $31.69 Check
JYHW Jan 19 $1.83 Check
AENY Jan 19 $4.51 Check
CLRH Dec 08 $1.35 Check
NXTH Dec 08 $2.28 Check
IMGG Nov 22 $1.39 Check
MEVT Nov 16 $0.35 Check
AWSL Nov 16 $3.29 Check
FRPT Oct 13 $5.84 Check
AEHI Oct. 4 $0.87 Check
URRE Nov 13 2.49 Check

The best new website for learning about penny-stock scams.

Airgain (AIRG): Looming Dilution, A Potshot From Its Own Underwriter ... And More!

by Sonya Colberg, Senior Editor, 9/26/2016 10:28:59 AM

TheStreetSweeper issues an alert for Airgain (AIRG) investors. This recent IPO has flown for no reason and now circumstances have aligned to suddenly take all the air out of Airgain.

*Development No. 1: Nearly 3 million shares registered late Friday

The wireless network antenna seller has taken advantage of the high stock price to set up employees for more gains. Almost two hours after the market closed on Friday, Airgain filed to register 2.69 million shares of stock available under various incentive plans ... 

(Source: Company SEC filing)

The issuance represents a cost to current investors ... looming potential dilution. And that's not all!

*Development No. 2:  1 million stock options pose immediate dilution

A second raft of potential dilution awaits investors, too.

Roughly 1 million options are exercisable immediately, according to the chief financial officer's comments during the earnings call 

Those options appear to be awfully cheap ... exercisable at just over $2 per share.

(Source: Company SEC filing)

But Airgain isn't finished diluting shares yet...

*Recent Development No. 3: Another ~5 million shares loom just around the corner

A third raft of potential dilution awaits investors in the form of ~5 million shares - in converted preferred shares, dividends and warrants. These shares have been held since the IPO in August and will be available for trading as soon as the 180-day lock-up period ends.

Imagine all the champagne-cork flying and caviar gulping at insiders' New Year's Eve parties as they begin celebrating their potentially huge payday around Feb. 7!

After all, the stock is trading ~94% higher than just six weeks ago.

(Source: Yahoo Finance)

And an odd circumstance has developed right on top of the dilution concerns ...

*Recent Development No. 4: Coverage only from its own underwriting firms ... and they're not even on the same page.



Everyday Health (EVDY): Quick, Call The Doctor!

by Sonya Colberg, Senior Editor, 9/22/2016 11:41:42 AM

Everyday Health (EVDY) is looking so pale that it may be secretly looking up its symptoms on rival website, WebMD.

Everyday had never exactly been the picture of health. The WebMD wannabe had racked up a $2.38 per share net loss when it went public in February 2014. The company made money in 2014 but slumped back to a $12 million loss or -$0.36 last year.

Housed in luxurious $4.5 million Manhattan suites far from Silicon Valley, Everyday is showing some disturbing symptoms exacerbated by its financial operations and the changing industry.

Here's how the prognosis looks to TheStreetSweeper:

Investors may find other viewpoints here plus additional risks and background here. Now let's look at why we think this healthcare search site needs to call the doctor.

*1. Google Changes

Ten years ago, WebMD was part of Google's experimental program to help improve health search results.

The experiment worked and WebMD became a popular site for consumers to diagnose their own illnesses. Before long, the Mayo Clinic developed its own well-recognized symptom checker.

Everyday Health and other content aggregators rushed in and began offering their solutions. The problem is that they must depend on Google searches because they aren't recognized brands.

Now a decade later Google wants to keep eyeballs glued to its own pages rather than rushing them away to the content aggregators.

Google began this effort in June, when it rolled out a new symptom search for Androids and Apple phones or tablets.

Now this mobile platform is pushing Google ahead of the game as more and more people switch from PC to smartphone searches.

*2. Looming: More Risk

Everyday Health and other content providers are dependent on Google, the No. 1 destination for health information: Get strong Google results or die.

Other risks are building right behind those posed by Google's new symptom search, including:

*The app is initially available in English in the U.S. with plans to expand over the months into other languages, countries and enhancements, thus introducing future challenges to Everyday Health.

*Google's symptom search eliminates the need to cross-check symptoms on WebMD or Everyday Health because cross-checking can be done on Google.

*Google is partnering on symptom search with institutions such as Harvard Medical School and the Mayo Clinic. Doctors are helping with Everyday Health's symptom lookup but most content is by writers who aren't doctors. Examples include:

(Source: Everyday Health)

*3. Mobile App Downloads Decline

Mobile is of growing importance to Everyday Health, which gets 75% of its total traffic from mobile.

Everyday's 2014 mobile revenues grew 82% to $68 million. But mobile has slowed drastically, with 2015 revenues hitting only $73 million or just 8% growth. However the company stopped breaking out mobile revenue after the third quarter of 2015, so we assume revenue growth has further declined.

The chief reason for the mobile disappointment is likely because iPhone users show far more interest in WebMD than Everyday. Everyday Health download rankings frequently fall below 1,500 in the health and fitness category:

 

(Source: App Annie)

That compares with WebMD's app which consistently ranks around the top 73 downloads:

(Source: App Annie)

An insidious threat has already taken a toll and is set up to kill much of the ability of sites like Everyday Health to make money from ads...

*4. Ad-Blockers Gobble Profitability Pathway

JAMN Finally Spills the Beans -- And It's an Ugly Mess

by Janice Shell, 6/2/2011 10:32:51 AM

* Editor's Note: Readers can access links to additional backup documents for this story by clicking here for TheStreetSweeper's original investigative report on this company.

Late Tuesday afternoon, after missing earlier deadlines, Jammin Java (OTC: JAMN.OB) filed a long-awaited annual report packed with enough eye-opening news to keep investors up all night. That mandatory filing, unaccompanied with a cheerful press release heralding its arrival, served as a painful wake-up call to shareholders already burned by a rapid plunge in the company’s stock price.

To be sure, the 10-K offered investors little reason to sing. For starters, the filing reveals, this once-hot “coffee company” sells no coffee of its own at all. JAMN relies on a supplier based in frigid Canada – far away from the tropical Jamaican home of its co-founder Rohan Marley – to provide the company with an actual product to sell to its customers instead.

Back in April of 2010, JAMN inked a “supply and toll agreement” with Canterbury Coffee of British Columbia that gave it access to some brew. According to that agreement, JAMN relies on Canterbury to fulfill every role – save a minor one – normally satisfied by a firm that classifies itself as a coffee company. Canterbury purchases the coffee beans. It roasts them. And it then packages them in bags supplied by JAMN – the company’s only real product – for sale to the public.

JAMN signed this deal more than a year ago, right before Shane Whittle – a notorious Vancouver stock promoter – officially resigned as CEO of the company. But the company never mentioned that agreement, seemingly material enough to warrant at least a quiet 8-K report, in a single regulatory filing until now.   

Jammin Java (JAMN): Hot Stock ... Bitter Aftertaste?

by Janice Shell, 6/2/2011 10:30:25 AM

It’s time to wake up and smell the coffee! That’s exactly what Jammin Java (OTC: JAMN.OB), a heavily promotedcoffee company, and – for very different reasons – TheStreetSweeper would like investors to do.

Since the beginning of the year, JAMN has miraculously risen from the ashes of the “Grey Market” graveyard to become one of the liveliest – and richest – stocks in the entire microcap arena. JAMN has seen its stock shoot straight toward heaven, soaring from 55 cents to peak above $6 a share on massive daily volume, with its market value nowtopping $355 million despite the company’s limited resources and operating history. (As covered in more detail below, two of the Internet tout sheets pushing JAMN the hardest effectively vanished -- disabled by their Internet servers -- on the day the stock’s trading volume exploded past 20 million shares.) 

JAMN stands out for its powerful connections, the first loudly celebrated by the company and the second – involving a notorious stock promoter – carefully hidden from view.


 

CCME: Few Signs of Life at 'Healthy' Chinese Firm

by Roddy Boyd, 3/23/2011 9:30:34 AM

* Editor's Note: This story has been republished with permission from The Financial Investigator. To access the original article, complete with links to back-up documents, click here.

In the maze of thronged and narrow streets that makes up Fujian province’s capital city of Fuzhou, a deft driver, if he’s willing–as all Chinese drivers apparently are–to nearly kill or injure vast numbers of his countrymen can take you to the foot of Dongjie street. There was little reason to be there save for its having the headquarters of a company called China MediaExpress Holdings (Nasdaq: CCME), an enterprise that seems to be able to weather allegations about its business that would have forced the share price collapse of a company five times its size. The attention of bulls and bears is not misplaced: In a mere four years as a public company, it has apparently come to dominate the ad placement market for leading multinational consumer products companies on a network of what it claims is more than 27,000 buses on Chinese airport and intercity routes.

Also, and this cannot be understated, hanging out on a sidewalk in Fujian–the sidewalks double as parking spots when the streets, which appeared to have been designed in the Han Dynasty, fill up–was not a viable option. There was also the matter of the world-class headache the Financial Investigator was developing from Fuzhou’s diabolical smell, an epic conflation of poor sewage treatment, air pollution and the smell of cabbage that made getting the hell off Dongjie street a matter of vital importance.

The Financial Investigator and his traveling companion for the trip, an American investor with extensive experience in China, decided to head upstairs despite our interview with the CFO having been cancelled at the last minute (with no explanation given.) We thought a quick tour of the offices and meeting a few other executives might open our eyes to a few things.

It did.

Though the language barrier was a little steep with the young receptionist–when we asked for writing paper, she provided Kleenex–we were in short order shown to their conference room and told to wait. It did not escape notice that pride of place in the conference room belonged to a framed certificate of participation from the Fall 2010 Rodman & Renshaw conference, the World Cup for reverse merger companies and the pumpers and touts who peddle them.

Eventually chief operating officer James Yu came down and after spending 30 minutes trying to understand who we were, concluded that giving us a tour wouldn’t hurt. Soon enough, his colleague, Vinne Ye–the chairman’s assistant–came out and took us around.

It was most eye-opening.

more...

Signup For Alerts
When new stories are published
Email:  

Barron's reports that TheStreetSweeper unravels an odd case of mistaken identity surrounding Skyline (SKY):

Read the Article
Read the SKY Story

The Street Sweeper Is Not A Fan of Glu Mobile Inc.'s Kim Kardashian Game (GLUU):

Read the Article
Read the GLUU Story

Glu Mobile Falls as Kardashian Game Drops in Rankings (GLUU):

Read the Article
Read the GLUU Story

CNBC on TheStreetSweeper's coverage of Gold Resource Corporation: (GORO):
"Herb Greenberg comments on Gold Resource Corporation"

Watch the Video
Read the GORO Story

CNBC on TheStreetSweeper's coverage of Miller Energy Resources: (MILL):
"Melissa Davis at TheStreetSweeper … wrote a piece on this thing that obviously scared investors a little bit … It was an excellent reporting job (and) has moved the stock dramatically."

Watch the Video
Read the MILL Story

Herb Greenberg's View (NOG):
"There are questions about related parties … Sometimes companies just don't pass that 'sniff test.'"

Watch the Video
Read the NOG Story

Cramer's View (SWSH): "I wouldn't touch Swisher with a 10-foot PLUNGER!"
Watch the Video
Read the SWSH Story

Cramer's View (NOG): "I clearly have been jarred by the accounting issues and feel like, right now, the momentum has left this stock."
Watch the Video
Read the NOG Story

New Article Alert! Sign up to get notified of new articles.  Click Here. Subscribe
     
| More

Investors must be properly armed in order to protect themselves against the dangers of Wall Street. To help out, The Street Sweeper has mined the Internet for the most powerful weapons available to investors researching publicly traded companies. In our “Loaded Weapons” section, you’ll find direct links to corporate documents filed with the SEC, conference call transcripts published by Seeking Alpha, insider stock sales tracked by Insider-Monitor.com and popular investment tools offered by Yahoo! Finance. You can also identify the promoters behind current penny stock campaigns – and the compensation they are receiving – by connecting to StockPromoters.com. You can link to other websites that are conducting topnotch stock investigations as well. Click here now.

When investors begin their homework on small-cap companies - particularly on penny stocks - they should probably start with an important history lesson. Specifically, they should conduct background checks on their stockbrokers and the companies those brokers are touting.
 
The Street Sweeper has designed a cheat sheet of sorts to help out with this research. Our “Rap Sheet” section links to a free tool (sponsored by FINRA) that allows ordinary investors to review the backgrounds of individual stockbrokers and their brokerage firms. The section also links to whistleblower cases and class-action lawsuits targeting publicly traded companies. It provides access to recent news of SEC enforcement actions and FBI white-collar crime investigations as well.
click here now.